Skip to Main Content

++

  • Distal pancreatic solid mass.
    • Neuroendocrine tumor.
    • Pancreatic adenocarcinoma.
    • Solid neoplasm of indeterminate diagnosis.
  • Distal pancreatic mucinous cystic neoplasms.
    • Asymptomatic, ≥ 3 cm in size.
    • Symptomatic, any size.
    • Presence of a solid component.
    • Dilated main pancreatic duct.
  • Distal pancreatic symptomatic serous cystadenoma.
  • Chronic calcific pancreatitis or small symptomatic pseudocyst limited to pancreatic tail (less common).

++

Absolute

++

  • Proximal mass requiring pancreatoduodenectomy.
  • Known metastatic disease.
  • Local invasion of structures that cannot be resected en bloc with the pancreas.
  • Mass encasing mesenteric vessels, with loss of usual fat planes noted on preoperative imaging (CT, MRI, or endoscopic ultrasound [EUS]).
  • Portal hypertension.

++

Relative

++

  • Cardiopulmonary comorbidities.
  • Splenic vein thrombosis.

++

Expected Benefits

++

  • Surgical cure of a neoplasm in the distal pancreas.
  • Prevention of malignant transformation of mucinous cystic neoplasms.
  • Treatment of symptomatic benign disease.

++

Potential Risks

++

  • Surgical site infection, bleeding, and damage to adjacent structures.
  • Removal of the spleen.
    • Should this be necessary, patients are at risk for the rare complication of post-splenectomy sepsis.
  • Complications unique to operations on the pancreas include:
    • Postoperative pancreatitis.
    • Pancreatic leaks.
    • Pancreatic fistula formation.

++

  • No special equipment is needed.
  • A self-retaining retractor helps facilitate exposure of the operative field.
  • A surgical energy device (eg, harmonic scalpel, LigaSure) is extremely useful.
  • Depending on surgeon preference, a surgical stapler may be used to transect the pancreatic tail. In that case, a thoracoabdominal (TA) or gastrointestinal anastomosis (GIA) stapler is used.

++

  • Thorough preoperative evaluation is essential before undertaking this procedure.
  • For symptomatic patients, delineation of the presenting symptoms and correlation of these symptoms with the mass in the pancreatic tail or body is critical.
  • Potentially useful tests include:
    • Abdominal CT, ultrasonography.
    • Endoscopic retrograde cholangiopancreatography (ERCP) or EUS.
    • Magnetic resonance cholangiopancreatography (MRCP).
  • For cystic neoplasms, cyst fluid is often obtained during EUS and analysis is performed to differentiate mucinous from serous cystic lesions and to determine cyst fluid CEA levels.
  • Side branch versus main duct intraductal papillary mucinous neoplasms should be differentiated preoperatively using ERCP, MRCP, or EUS, if at all possible.
  • Patients with persistent hypoglycemia and suspected insulinoma should receive glucose supplementation.
  • Patients with refractory ulcers, elevated gastrin levels, and the suspicion of a gastrinoma should receive preoperative treatment for acid secretion and appropriate fluid and electrolyte supplementation.
  • If splenectomy is planned, patients should undergo immunization for encapsulated organisms at least 2 weeks before surgery.

++

  • The patient should be supine.
  • The skin is prepared from the level of the nipples to the pubis, extending along the flank.
  • The abdomen is entered through a midline incision.
  • Alternatively, a bilateral subcostal incision may be used.

++

  • Figure 16–1: Ligation of the short gastric vessels.
    • For resection of the distal pancreas, the standard approach is through an upper midline incision.
    • The pancreas is approached as in other pancreatic procedures through the lesser sac of the omentum.
    • ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessSurgery Full Site: One-Year Subscription

Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessSurgery

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.